Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Could Vertex Have a Cure for Type 1 Diabetes on the Way?


Vertex Pharmaceuticals (NASDAQ: VRTX) reported positive results in October from an early stage clinical study evaluating VX-880 in treating type 1 diabetes. The New York Times recently published an article about these results, suggesting that Vertex could even have a cure for type 1 diabetes. 

In this Motley Fool Live video recorded on Dec. 1, 2021, Motley Fool contributors Keith Speights and Brian Orelli answer a viewer's question about Vertex's experimental diabetes therapy.

Continue reading


Source Fool.com

Like: 0
Share

Comments